Synonyms: Noxafil® | SCH-56592 | SCH56592 | Schering 56592
posaconazole is an approved drug (EMA (2005), FDA (2006))
Compound class:
Synthetic organic
Comment: Posaconazole is a broad-spectrum, second generation, antifungal drug. It inhibits the fungal lanosterol 14α-demethylase, which reduces production of ergosterol (an important component of the fungal cell wall).
|
|
No information available. |
Summary of Clinical Use ![]() |
Used to prevent invasive fungal infections due to Aspergillosis, Candida, Scedosporium and Fusarium species in high risk patients. |
External links ![]() |
For extended ADME data see the following: European Medicines Agency (EMA) |